Alabama police officer shot and killed a 68-year-old knife wielding man with dementia

MONTGOMERY, Ala. (AP) — An Alabama police officer is being investigated for allegedly shooting and killing a 68-year-old man with dementia after his family called for help on Sunday, according to authorities and the family's lawyer. A Muscle Shoals police officer fatally shot...

Ex-Vikings QB Kramer says he has dementia, inspired to share by Favre's revelation of Parkinson's

MINNEAPOLIS (AP) — Former Minnesota Vikings quarterback Tommy Kramer has been diagnosed with dementia, he announced on social media. The 69-year-old Kramer, who played 13 of his 14 seasons in the NFL with the Vikings and made the Pro Bowl after leading the league in passer rating...

US-based researchers win $1 million prize for their work on face recognition

LISBON, Portugal (AP) — Four researchers working in the United States are sharing a $1 million prize from a Portuguese foundation for their work on how the human brain distinguishes faces, shapes and colors. Americans Margaret Livingstone of Harvard Medical School, Nancy Kanwisher...

Wildfire smoke may be worse for your brain than other air pollution, study says

Wildfire smoke may be worse for brain health than other types of air pollution, according to new research linking it to an increased risk of dementia. The findings, reported Monday at the Alzheimer’s Association International Conference in Philadelphia, come as millions spent the...

Blood tests for Alzheimer's may be coming to your doctor's office. Here's what to know

WASHINGTON (AP) — New blood tests could help doctors diagnose Alzheimer’s disease faster and more accurately, researchers reported Sunday – but some appear to work far better than others. It’s tricky to tell if memory problems are caused by Alzheimer’s. That requires...

Researchers report that a blood test can help doctors diagnose Alzheimer's faster and more accurately

European committee says Alzheimer's treatment Leqembi shouldn't get marketing approval

Shares of Biogen slid Friday after a European regulatory committee said the Alzheimer’s treatment Leqembi should not receive marketing approval. The European Medicines Agency committee said concerns about the drug’s potential side effects outweigh the impact it has in slowing the...

FDA approves a second Alzheimer's drug that can modestly slow disease

WASHINGTON (AP) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment. The Food and Drug Administration approved Eli Lilly’s Kisunla on...

FDA approves a second Alzheimer’s drug that can slow the disease by several months